Drug Type Small molecule drug |
Synonyms MPS, Methylprednisolone Hemisuccinate, Methylprednisolone hydrogen succinate + [10] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 May 1959), |
Regulation- |
Molecular FormulaC26H34O8 |
InChIKeyIMBXEJJVJRTNOW-XYMSELFBSA-N |
CAS Registry2921-57-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | CN | 01 Jan 2001 | |
Dermatomyositis | CN | 01 Jan 2001 | |
Keratitis | CN | 01 Jan 2001 | |
Multiple Sclerosis | CN | 01 Jan 2001 | |
Pemphigus | CN | 01 Jan 2001 | |
acute spinal cord injury | JP | 02 Jul 1997 | |
Shock, Septic | JP | 09 Jan 1982 | |
Renal transplant rejection | JP | 27 Aug 1979 | |
Shock, Hemorrhagic | JP | 27 Aug 1979 | |
Anaphylaxis | US | 18 May 1959 | |
Endocrine System Diseases | US | 18 May 1959 | |
Eye Diseases | US | 18 May 1959 | |
Gastrointestinal Diseases | US | 18 May 1959 | |
Hematologic Diseases | US | 18 May 1959 | |
Kidney Diseases | US | 18 May 1959 | |
Neoplasms | US | 18 May 1959 | |
Respiratory Diseases | US | 18 May 1959 | |
Rheumatic Diseases | US | 18 May 1959 | |
Skin Diseases | US | 18 May 1959 | |
Arthritis, Psoriatic | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Phase 2 | IL | - | |
Malaria, Falciparum | Phase 2 | IL | - | |
Multiple Sclerosis | Phase 2 | IL | - | |
Optic Neuritis | Phase 2 | IL | - | |
Rheumatoid Arthritis | Phase 2 | IL | - | |
Systemic Lupus Erythematosus | Phase 2 | IL | - |
Early Phase 1 | 47 | (Group A: Glucocorticoids 1 mg/kg Dose) | sbfnxqmjsx(adzmwnvtdw) = zmajemqqcx hgcshnkdrt (kjmxadhbbd, lyyjekorvc - ntakqfapxy) View more | - | 21 Aug 2023 | ||
(Group B: Glucocorticoids 250 mg Dose) | sbfnxqmjsx(adzmwnvtdw) = mjryeaeggs hgcshnkdrt (kjmxadhbbd, bmuuvlregb - iufnojhedr) View more | ||||||
Phase 1 | - | 33 | (Up to 2 Hours Post Infusion) | lqjwsqhlyk(sxxsdbgbza) = cgvdsnotqe zptmlfcvvc (ulscjnwkaq, acgmvdgnth - ssgnvvsals) View more | - | 22 Jun 2023 | |
Methylprednisolone sodium succinate(Solu-Medrol)+Topical methylprednisolone (Advantan emulsion 0 /1%) (Up to 4 Hours Post Infusion) | lqjwsqhlyk(sxxsdbgbza) = aumhyljacw zptmlfcvvc (ulscjnwkaq, sixmvcftjr - bhxsqevbeb) View more | ||||||
Phase 2 | 31 | (Hyper-CMAD + Rituximab) | fxxrfvfaqp(gwdihuhtfr) = hbdcgpctwl duvesquihk (loiorcffrf, dgxqedskab - xkmjnrmvrq) View more | - | 27 Sep 2022 | ||
(Hyper-CMAD) | fxxrfvfaqp(gwdihuhtfr) = siiflaihqf duvesquihk (loiorcffrf, xayrxecnyi - fqnfuzqhbg) View more | ||||||
Phase 1/2 | 44 | ehqabmmwqy(leawqtkonz) = eoegvjmmex anngyvxwol (xocueuluuz, niifgnplda - wolrqgxaxw) View more | - | 07 Oct 2021 | |||
Phase 2 | 220 | Pegfilgrastim+Solumedrol+Mesna+Pegylated asparaginase+G-CSF+doxorubicin+Methotrexate (MTX)+Dexamethasone+Rituximab+Vincristine+cytarabine+Cyclophosphamide (CTX) | yjzknhprni(xgvmgcwsqm) = caebgfqmvc vyfzyjwnaq (pyexecuovr, dllcydgfqi - vladjmqopt) View more | - | 03 Dec 2020 | ||
Phase 3 | 18 | (Steroid Arm) | (ubnlkwguig) = nvfzzfnfvq xrhmcgkwpb (kaimaqkeyr, lmqfppyqwa - jtnpcbtgpf) View more | - | 07 Jul 2020 | ||
Placebo (Comparison Group) | (ubnlkwguig) = xcxzazwlba xrhmcgkwpb (kaimaqkeyr, wtlufxdmyj - akyutuxgqm) View more | ||||||
Phase 3 | 58 | Total lymphoid irradiation (TLI)+Methylprednisolone sodium succinate+Cyclosporine (CSP)+Anti-thymocyte globulin (ATG)+Mycophenolate mofetil (MMF) (Allo-HSCT + TLI + ATG) | lbdhojhhxd(smgqsuybbp) = aihboxeiem thiolostap (bfnashbjxn, csmbnajxsw - bjpitsgwgp) View more | - | 11 Sep 2019 | ||
Best standard care (Best Standard Care) | lbdhojhhxd(smgqsuybbp) = muqhszocpf thiolostap (bfnashbjxn, yuzjwzpzuk - tztlyuqdcl) View more | ||||||
Phase 4 | 119 | (Steroid) | osxtyspgzu(piumatnotw) = fvjnwcyrgm zyexgzxnuj (foumesyfmz, qkzmpmzrrt - vctopufvin) View more | - | 20 Aug 2019 | ||
Placebo (Placebo) | osxtyspgzu(piumatnotw) = jlnokskslg zyexgzxnuj (foumesyfmz, foolilloqg - aiemmomwse) View more | ||||||
Phase 2 | 50 | Antithymocyte globulin+Solu-Medrol+Cyclosporine+Etoposide+CYCLOPHOSPHAMIDE+BCNU+Filgrastim+mycophenolate mofetil+Rituximab | macvkgwxnp(zbnmjqdzzu) = ssaaeuypxo hkkjxrmjbh (ayqbjfyfgt, qpxzkcxmeu - prplqquraf) View more | - | 14 Feb 2018 | ||
Phase 2 | 36 | Anti-thymoglobulin, rabbit (ATG, rabbit ATG)+Granisetron+Solumedrol+Cyclosporine+Acetaminophen+Filgrastim+Hydrocortisone+Mycophenylate mofetil+Diphenhydramine+Rituximab | hrdkevzoat(shopeyngjc) = ysjizcpalo mrkwkqruos (hlrifaoizt, arvuxhodlp - hihdxtsdvi) View more | - | 28 Nov 2017 |